<unk>  is a Rho kinase inhibitor that is FDA approved for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.   Common adverse reactions include conjunctival hyperemia, corneal verticillata, instillation site pain, and conjunctival hemorrhage.
Netarsudil
Bioallethrin
Ecallantide
Olaflur
Tioclomarol
Oprelvekin
Phenkapton
Irofulven